| DOXWX | IEVAX | DOXWX / IEVAX | |
| Total Expense Ratio | 0.52 | 1.12 | 46% |
| Annual Report Gross Expense Ratio | 0.57 | 1.12 | 51% |
| Fund Existence | 4 years | 31 years | - |
| Gain YTD | 22.976 | 17.467 | 132% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 2500 | 2000 | 125% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 12.6B | 855M | 1,474% |
| Annual Yield % from dividends | 1.66 | 1.63 | 102% |
| Returns for 1 year | 3.96 | 9.81 | 40% |
| Returns for 3 years | 30.70 | 28.78 | 107% |
| Returns for 5 years | N/A | 27.16 | - |
| Returns for 10 years | N/A | 37.92 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HAWX | 39.83 | 0.23 | +0.58% |
| iShares Currency Hdgd MSCI ACWI exUS ETF | |||
| JFR | 7.99 | 0.02 | +0.25% |
| Nuveen Floating Rate Income Fund | |||
| FLQS | 42.76 | -0.02 | -0.04% |
| Franklin US Small Cap Mltfctr Idx ETF | |||
| DUKH | 24.43 | -0.02 | -0.08% |
| Ocean Park High Income ETF | |||
| BIS | 10.19 | -0.05 | -0.51% |
| ProShares UltraShort Nasdaq Biotech | |||